查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598449

组织消融市场：按类型、技术、适应症分类 - 2025-2030 年全球预测

Tissue Ablation Market by Type (Minimally Invasive Surgery, Open Surgery), Technology (Cryoablation, Electrical Ablation, Hydromechanical Ablation), Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年组织消融市场估值为194.1亿美元，预计到2024年将达到208.7亿美元，复合年增长率为7.64%，到2030年将达到325亿美元。

组织消融是一种医疗程序，涉及去除或破坏异常或不必要的组织，通常使用射频、雷射、微波或超音波等能量类型。该技术由于其微创方法可减少恢復时间和手术风险，因此在肿瘤学、心臟病学和皮肤病学等多个领域具有重要意义。组织消融的应用范围包括治疗癌性肿瘤、心律不整和子宫肌瘤等良性肿瘤。最终用途包括提供先进医疗护理并需要先进消融技术的医院、诊所和专科手术中心。

主要市场统计
基准年[2023] 194.1亿美元
预测年份 [2024] 208.7亿美元
预测年份 [2030] 325亿美元
复合年增长率（%） 7.64%

全球组织消融市场受到多种成长要素的影响，包括提高精度和有效性的技术进步、寻求创新治疗方法的慢性疾病数量的增加以及微创手术的成长趋势。此外，世界人口老化对符合调查方法的治疗方法提出了巨大的潜在需求。机会在于扩大适应症和改进现有技术，从而增加其在各种医疗程序中的使用。透过利用人工智慧和机器学习，公司可以提高手术成功率和患者治疗效果。

然而，市场受到一些挑战的限制，例如先进消融系统的高成本、缺乏执行这些手术的熟练专业人员以及减缓产品核可流程的严格法规环境。此外，新兴国家也面临医疗基础设施不足等障碍。

研究和开发的创新领域包括开发可携式、经济高效的消融设备、生物靶向消融技术以及结合诊断和消融功能以实现更个性化治疗的整合平台。市场动态是动态的，其特点是快速的技术创新和持续的研究。寻求发展的公司专注于与医疗保健提供者合作，以展示价值和有效性，投资于研究和开发以持续改进消融设备，并利用其相对于传统方法的优势。。

市场动态：揭示快速发展的组织消融市场的关键市场洞察

供需的动态交互作用正在改变组织消融市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病和人口老化的流行
    • 技术进步和 MI 程序的增加
    • 越来越多在肿瘤手术中使用医用雷射
  • 市场限制因素
    • 严格规定
  • 市场机会
    • 机器人导航技术的发展
    • 轻鬆获得先进的雷射消熔治疗
  • 市场挑战
    • 缺乏熟练的专业人员

波特五力：驾驭组织消融市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解组织消融市场的外部影响

外部宏观环境因素在塑造组织消融市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解组织消融市场的竞争状况

组织消融市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵组织消融市场供应商绩效评估

FPNV定位矩阵是评估组织消融市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定组织消融市场成功之路的策略分析与建议

组织消融市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病盛行率和老年人口
      • 技术进步和 MI 程序的增加
      • 越来越多在肿瘤手术中使用医用雷射
    • 抑制因素
      • 严格监管之路
    • 机会
      • 机器人导航技术的发展
      • 获得先进的雷射消熔治疗
    • 任务
      • 缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章组织消融市场：依类型

  • 微创手术
  • 开放性手术

第七章组织消融市场：依技术分类

  • 冷冻疗法
  • 电消融
  • 流体机械消融
  • 光/雷射消熔
  • 微波消融
  • 射频消融术
  • 超音波消融

第八章组织消融市场（按适应症）

  • 心臟病学
  • 美丽
  • 妇科
  • 肿瘤学
  • 眼科
  • 泌尿系统

第九章美洲组织消融市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太组织消融市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲组织消融市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Alcon Inc.
  • Angiodynamics, Inc.
  • Atricure, Inc.
  • Biosense Webster Inc.
  • Boston Scientific Corporation
  • CR Bard Inc.
  • Ethicon, Inc.
  • Galil Medical, Inc.
  • HealthTronics, Inc.
  • HS Hospital Service SPA
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Misonix, Inc.
  • NeuWave Medical, Inc.
  • Olympus Corporation
  • Smith & Nephew Plc
  • SonaCare Medical LLC
  • Stryker Corporation
Product Code: MRR-03100B7643D6

The Tissue Ablation Market was valued at USD 19.41 billion in 2023, expected to reach USD 20.87 billion in 2024, and is projected to grow at a CAGR of 7.64%, to USD 32.50 billion by 2030.

Tissue ablation is a medical procedure that involves the removal or destruction of abnormal or unwanted tissue, often utilizing energy types such as radiofrequency, laser, microwave, or ultrasound. This technique is crucial in various fields, including oncology, cardiology, and dermatology, owing to its minimally invasive approach which reduces recovery time and surgical risks. Applications of tissue ablation span across treatments for cancer tumors, cardiac arrhythmias, and benign growths like fibroids. The end-use scope includes hospitals, clinics, and specialized surgical centers that provide such advanced medical care and require sophisticated ablation technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 19.41 billion
Estimated Year [2024] USD 20.87 billion
Forecast Year [2030] USD 32.50 billion
CAGR (%) 7.64%

The global market for tissue ablation is influenced by several growth factors, including technological advancements that enhance precision and efficacy, an increasing prevalence of chronic diseases that demand innovative treatment options, and a growing trend toward minimally invasive surgeries. Moreover, the aging global population presents a vast potential demand for treatments consistent with tissue ablation methodologies. Opportunities lie in expanding indications and improving existing technologies, thereby increasing their use in diverse medical procedures. Companies could leverage artificial intelligence and machine learning to enhance procedural success rates and patient outcomes.

However, the market is constrained by challenges such as high costs of advanced ablation systems, a lack of skilled professionals capable of performing these procedures, and stringent regulatory environments that slow product approval processes. Additionally, emerging economies face barriers like inadequate healthcare infrastructure.

Innovative areas ripe for research include the development of portable and cost-effective ablation devices, bio-targeted ablation techniques, and integrated platforms that combine diagnostic and ablation capabilities for more personalized treatments. The tissue ablation market is dynamic, characterized by rapid technological change and ongoing research. Companies aiming for growth should focus on partnerships with healthcare providers to demonstrate value and efficacy, invest in R&D for the continual improvement of ablation devices, and educate stakeholders on advantages over traditional methods to drive adoption.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Ablation Market

The Tissue Ablation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic diseases and geriatric population
    • Technology advancements and increase in MI procedures
    • Increased use of medical lasers for oncology procedures
  • Market Restraints
    • Stringent regulatory path
  • Market Opportunities
    • Development in robotic navigation technologies
    • Accessibility to advanced laser ablation treatments
  • Market Challenges
    • Dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Ablation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Ablation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Ablation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Ablation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Ablation Market

A detailed market share analysis in the Tissue Ablation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Ablation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Ablation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Ablation Market

A strategic analysis of the Tissue Ablation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Ablation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alcon Inc., Angiodynamics, Inc., Atricure, Inc., Biosense Webster Inc., Boston Scientific Corporation, C.R Bard Inc., Ethicon, Inc., Galil Medical, Inc., HealthTronics, Inc., HS Hospital Service S.P.A, Johnson & Johnson Services, Inc., Medtronic PLC, Misonix, Inc., NeuWave Medical, Inc., Olympus Corporation, Smith & Nephew Plc, SonaCare Medical LLC, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Tissue Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Minimally Invasive Surgery and Open Surgery.
  • Based on Technology, market is studied across Cryoablation, Electrical Ablation, Hydromechanical Ablation, Light/Laser Ablation, Microwave Ablation, Radiofrequency Ablation, and Ultrasound Ablation.
  • Based on Indication, market is studied across Cardiology, Cosmetology, Gynecology, Oncology, Ophthalmology, and Urology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and geriatric population
      • 5.1.1.2. Technology advancements and increase in MI procedures
      • 5.1.1.3. Increased use of medical lasers for oncology procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory path
    • 5.1.3. Opportunities
      • 5.1.3.1. Development in robotic navigation technologies
      • 5.1.3.2. Accessibility to advanced laser ablation treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tissue Ablation Market, by Type

  • 6.1. Introduction
  • 6.2. Minimally Invasive Surgery
  • 6.3. Open Surgery

7. Tissue Ablation Market, by Technology

  • 7.1. Introduction
  • 7.2. Cryoablation
  • 7.3. Electrical Ablation
  • 7.4. Hydromechanical Ablation
  • 7.5. Light/Laser Ablation
  • 7.6. Microwave Ablation
  • 7.7. Radiofrequency Ablation
  • 7.8. Ultrasound Ablation

8. Tissue Ablation Market, by Indication

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Cosmetology
  • 8.4. Gynecology
  • 8.5. Oncology
  • 8.6. Ophthalmology
  • 8.7. Urology

9. Americas Tissue Ablation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tissue Ablation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Ablation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alcon Inc.
  • 3. Angiodynamics, Inc.
  • 4. Atricure, Inc.
  • 5. Biosense Webster Inc.
  • 6. Boston Scientific Corporation
  • 7. C.R Bard Inc.
  • 8. Ethicon, Inc.
  • 9. Galil Medical, Inc.
  • 10. HealthTronics, Inc.
  • 11. HS Hospital Service S.P.A
  • 12. Johnson & Johnson Services, Inc.
  • 13. Medtronic PLC
  • 14. Misonix, Inc.
  • 15. NeuWave Medical, Inc.
  • 16. Olympus Corporation
  • 17. Smith & Nephew Plc
  • 18. SonaCare Medical LLC
  • 19. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. TISSUE ABLATION MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE ABLATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TISSUE ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TISSUE ABLATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TISSUE ABLATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TISSUE ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TISSUE ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TISSUE ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TISSUE ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TISSUE ABLATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TISSUE ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TISSUE ABLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TISSUE ABLATION MARKET DYNAMICS
  • TABLE 7. GLOBAL TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TISSUE ABLATION MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE ABLATION MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TISSUE ABLATION MARKET SIZE, BY ELECTRICAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TISSUE ABLATION MARKET SIZE, BY HYDROMECHANICAL ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TISSUE ABLATION MARKET SIZE, BY LIGHT/LASER ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TISSUE ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE ABLATION MARKET SIZE, BY ULTRASOUND ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TISSUE ABLATION MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TISSUE ABLATION MARKET SIZE, BY COSMETOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TISSUE ABLATION MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TISSUE ABLATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TISSUE ABLATION MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TISSUE ABLATION MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES TISSUE ABLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA TISSUE ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM TISSUE ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM TISSUE ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM TISSUE ABLATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. TISSUE ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. TISSUE ABLATION MARKET, FPNV POSITIONING MATRIX, 2023